31 Jan 2007 |
OctoPlus initiates Locteron Phase II clinical study in chronic hepatitis C
|
31 Jan 2007 |
ZymoGenetics Begins Clinical Trial for PEG-Interferon lambda as Potential Treatment for Viral Infection
|
31 Jan 2007 |
Alfacell Corporation Granted U.S. Orphan Drug Designation for ONCONASE(R) for Treatment of Malignant Mesothelioma
|
30 Jan 2007 |
ReceptoPharm Begins Phase IIb Human Clinical Trial for the Treatment of Adrenomyeloneuropathy
|
27 Jan 2007 |
Largest-ever stroke registry confirms safety of Actilyse(R) thrombolysis treatment for acute ischaemic stroke
|
26 Jan 2007 |
Bayer discontinues Trasylol(R) clinical trial program in non-CABG indications
|
26 Jan 2007 |
Spectrum Pharmaceuticals Initiates Phase 2b Trial for Ozarelix in Patients with Benign Prostate Hypertrophy
|
26 Jan 2007 |
Altea Therapeutics Announces Positive Clinical Results for its Basal Insulin Transdermal Patch
|
26 Jan 2007 |
BioMimetic Therapeutics Reports Positive Clinical Results Using GEM OS®1 to Treat Distal Radius Fractures
|
25 Jan 2007 |
Scil Technology Completes Patient Enrollment in European Phase II Sinus Lift Study
|
25 Jan 2007 |
Molecular Insight Pharmaceuticals, Inc. Acquires Clinical Stage, Targeted Radiotherapeutic Candidate Onalta(TM) (Formerly OctreoTher(TM))
|
23 Jan 2007 |
Halozyme Therapeutics Releases Results of Enhanze Technology Clinical Trial to Improve the Subcutaneous Absorption of a Large Protein Molecule Therapeutic
|
23 Jan 2007 |
Discovery Labs and FDA Reach Clarity On Path Towards Surfaxin RDS Approval
|
23 Jan 2007 |
MIGENIX Announces Initiation of Rosacea Phase II Clinical Study by Partner, Cutanea Life Sciences
|
23 Jan 2007 |
Artielle ImmunoTherapeutics, Inc., and QSV Biologics, Ltd. Sign Contract for cGMP Manufacture of RTL 1000 for Multiple Sclerosis
|
19 Jan 2007 |
Protox Reports Promising Interim Results From Prostate Cancer Study
|
19 Jan 2007 |
CSC'S DVC And Baxter Begin Phase 1 Clinical Trial For Chemical Defense Product
|
18 Jan 2007 |
MGI PHARMA Announces Publication of Phase 3 Data for Saforis(TM) (glutamine) Powder in UpTec(TM) for Oral Suspension in Cancer
|
18 Jan 2007 |
Lev Pharmaceuticals, Inc. Announces Final Patient Treated In Pivotal Phase III HAE Trial
|
17 Jan 2007 |
Oxford Biomedica Announces Publication Of Avian Transgenic Results In Leading U.S. Scientific Journal
|
17 Jan 2007 |
Largest-ever Fabry study shows earlier treatment with (Pr)Fabrazyme(R) 1 mg/kg means less damage from rare Fabry disease
|
17 Jan 2007 |
Pharming Receives European Orphan Drug Designation
|
17 Jan 2007 |
Neose Receives Approval to Commence Phase II Clinical Trial For NE-180
|
16 Jan 2007 |
Genzyme Announces Publication of Study Showing Impact of Cerezyme on Bone Health for Patients with Type 1 Gaucher Disease
|
16 Jan 2007 |
FDA accepts for filing a New Drug Application (NDA) for Somatuline(R) Autogel(R)
|